title: Functional identification of a novel transport system for endogenous and synthetic opioid peptides in the rabbit conjunctival epithelial cell line CJVE.
abstract: OBJECTIVE
  To investigate whether conjunctival epithelial cells express transport processes for opioid peptides.
  
  
  METHODS
  We monitored the uptake of [(3)H]deltorphin II and [(3)H]DADLE, two hydrolysis-resistant synthetic opioid peptides, in the rabbit conjunctival epithelial cell line CJVE and elucidated the characteristics of the uptake process.
  
  
  RESULTS
  CJVE cells express robust uptake activity for deltorphin II and DADLE. Both opioid peptides compete with each other for transport. Several endogenous and synthetic opioid peptides, but not non-peptide opioid antagonists, are recognized by the transport process. Though various peptides inhibit the uptake of deltorphin II and DADLE in a similar manner, the uptake of deltorphin II is partly Na(+)-dependent whereas that of DADLE mostly Na(+)-independent. The transport process shows high affinity for many endogenous/synthetic opioid peptides. Functional features reveal that this transport process may be distinct from the opioid peptide transport system described in the retinal pigment epithelial cell line ARPE-19 and also from the organic anion transporting polypeptides, which are known to transport opioid peptides.
  
  
  CONCLUSIONS
  CJVE cells express a novel, hitherto unknown transport process for endogenous/synthetic opioid peptides. This new transport process may offer an effective delivery route for opioid peptide drugs to the posterior segment of the eye.
authors.affiliation: Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta, Georgia 30912, USA.
authors.forename: Sudha
authors.initials: S
authors.lastname: Ananth
authors.forename: Senthil
authors.initials: S
authors.lastname: Karunakaran
authors.forename: Pamela M
authors.initials: PM
authors.lastname: Martin
authors.forename: Chandrasekharam N
authors.initials: CN
authors.lastname: Nagineni
authors.forename: John J
authors.initials: JJ
authors.lastname: Hooks
authors.forename: Sylvia B
authors.initials: SB
authors.lastname: Smith
authors.forename: Puttur D
authors.initials: PD
authors.lastname: Prasad
authors.forename: Vadivel
authors.initials: V
authors.lastname: Ganapathy
mesh_terms: D000584:Amiloride / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D001692:Biological Transport / Q000187:drug effects*; D002460:Cell Line; D003228:Conjunctiva / Q000166:cytology*; D016308:Enkephalin, Leucine-2-Alanine / Q000493:pharmacokinetics; D004847:Epithelial Cells / Q000378:metabolism*; D009270:Naloxone / Q000494:pharmacology; D009842:Oligopeptides / Q000493:pharmacokinetics; D018847:Opioid Peptides / Q000493:pharmacokinetics*; D027361:Organic Anion Transporters / Q000037:antagonists & inhibitors; D011817:Rabbits; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors
chemical_list: D009842:Oligopeptides; D018847:Opioid Peptides; D027361:Organic Anion Transporters; C060209:deltorphin II, Ala(2)-; D009270:Naloxone; C039465:5-dimethylamiloride; D016308:Enkephalin, Leucine-2-Alanine; D000584:Amiloride; D000254:Sodium-Potassium-Exchanging ATPase
references.citation: Immunopharmacology. 1999 Apr;41(3):187-97
references.pmid: 10428647
references.citation: Eur J Pharm Biopharm. 2005 Jul;60(2):227-40
references.pmid: 15939235
references.citation: Mol Cell Biol. 1984 Aug;4(8):1653-6
references.pmid: 6092928
references.citation: J Pharmacol Exp Ther. 2000 Jul;294(1):73-9
references.pmid: 10871297
references.citation: Annu Rev Microbiol. 2001;55:165-99
references.pmid: 11544353
references.citation: Toxicol Appl Pharmacol. 2005 May 1;204(3):216-37
references.pmid: 15845415
references.citation: Eur J Pharm Sci. 2000 Jan;9(3):265-70
references.pmid: 10594383
references.citation: J Pharm Pharmacol. 2008 May;60(5):543-85
references.pmid: 18416933
references.citation: Pflugers Arch. 2004 Feb;447(5):653-65
references.pmid: 14579113
references.citation: Int J Toxicol. 2006 Jul-Aug;25(4):231-59
references.pmid: 16815813
references.citation: AAPS J. 2005 Dec 29;7(4):E852-6
references.pmid: 16594637
references.citation: Eur J Pharmacol. 2008 Apr 14;584(1):57-65
references.pmid: 18321482
references.citation: J Biol Chem. 1990 Sep 5;265(25):14870-4
references.pmid: 2394703
references.citation: J Biol Chem. 1997 Jan 24;272(4):2110-5
references.pmid: 8999910
references.citation: Trends Neurosci. 1996 Jan;19(1):31-5
references.pmid: 8787139
references.citation: Proc Natl Acad Sci U S A. 1989 Jul;86(13):5188-92
references.pmid: 2544892
references.citation: J Biol Chem. 1987 May 15;262(14):6546-51
references.pmid: 3571270
references.citation: Gastroenterology. 2001 Feb;120(2):525-33
references.pmid: 11159893
references.citation: J Pharm Pharmacol. 2003 Jul;55(7):1013-20
references.pmid: 12906759
references.citation: Ophthalmic Res. 1993;25(6):378-85
references.pmid: 8309677
references.citation: Brain Res. 1998 May 4;792(1):72-8
references.pmid: 9593829
references.citation: Invest Ophthalmol Vis Sci. 1993 Aug;34(9):2665-71
references.pmid: 7688358
references.citation: Biochem J. 2003 Oct 1;375(Pt 1):17-22
references.pmid: 12924983
references.citation: Can J Biochem Physiol. 1962 Aug;40:1101-10
references.pmid: 13859741
references.citation: Ophthalmology. 2008 Feb;115(2 Suppl):S13-20
references.pmid: 18243927
references.citation: Curr Drug Metab. 2004 Feb;5(1):85-94
references.pmid: 14965252
references.citation: Acta Histochem. 1992;93(1):319-32
references.pmid: 1382351
references.citation: Cell Host Microbe. 2007 Jun 14;1(4):299-308
references.pmid: 18005709
references.citation: J Pharmacol Exp Ther. 2007 Apr;321(1):257-64
references.pmid: 17259448
references.citation: Clin Exp Pharmacol Physiol. 1985 Mar-Apr;12(2):107-13
references.pmid: 4006315
references.citation: Brain Res. 1997 Jun 6;759(1):92-102
references.pmid: 9219867
references.citation: J Membr Biol. 1985;84(2):97-103
references.pmid: 3999130